Racura Oncology Ltd (formerly known as Race Oncology Limited) Appendix 4E Preliminary final report 1 Racura Oncology Ltd 1. Company details Name of entity: Racura Oncology Ltd (formerly known as Race Oncology Limited) ABN: 61 149 318 749 Reporting period: For...
Appendix 4E & Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Racura Oncology
- First HARNESS-1 Patient Safely Treated with RC220
- Racure Oncology Techknow Invest Presentation
- June 2026 Quarterly Activities Report and Appendix 4C
- Bellberry Ethics Approval Activates New HARNESS Trial Sites
- Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer
Later from Racura Oncology
- Appendix 4G
- Corporate Governance Statement
- CPACS Trial Opens for RC220 Patient Enrolment in Korea
- Notification regarding unquoted securities - RAC
- Racura Oncology Adelaide Investor Briefing
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology